Article
Single molecule localization microscopy coupled with touch preparation for the quantification of trastuzumab-bound HER2
5 Oct 2018
Abstract excerpt
All breast cancers are assessed for levels of human epidermal growth factor receptor 2 (HER2). Fluorescence in situ hybridization (FISH) and immunohistochemistry are currently used to determine if a patient is eligible for anti-HER2 therapy. Limitations of both tests include variability and relatively long processing times. Additionally, neither test determines whether HER2 contains the extracellular domain....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
